Stockreport

Gilead Sciences Announces Fourth Quarter and Full Year 2025 Financial Results

Gilead Sciences, Inc.  (GILD) 
Last gilead sciences, inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.gilead.com
PDF Product Sales Excluding Veklury Increased 4% Year-Over-Year to $28.0 billion for Full Year 2025Biktarvy Sales Increased 7% Year-Over-Year to $14.3 billion for Full Year [Read more]